Related Experiment Videos

Antiproliferative effect of Angelica archangelica fruits

Steinthor Sigurdsson1, Helga M Ogmundsdottir, Sigmundur Gudbjarnason

  • 1Science Institute, University of Iceland, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland. sts@raunvis.hi.is

Insights

Angelica archangelica tincture shows significant antiproliferative effects against human pancreatic cancer cells. Its activity is primarily driven by furanocoumarins, imperatorin and xanthotoxin.

Area of Science:

  • Phytochemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Pancreatic cancer remains a significant health challenge with limited treatment options.
  • Natural products are a promising source for novel anticancer agents.
  • Angelica archangelica is traditionally used in herbal medicine.

Purpose of the Study:

  • To investigate the antiproliferative effects of Angelica archangelica fruit tincture on human pancreatic cancer cells (PANC-1).
  • To identify the active components responsible for the observed anticancer activity.

Main Methods:

  • In vitro study using the PANC-1 human pancreatic cancer cell line.
  • Treatment with Angelica archangelica tincture and isolated compounds.
  • Dose-dependent antiproliferative activity assessment using EC50 values.

Main Results:

  • The Angelica archangelica tincture exhibited significant dose-dependent antiproliferative activity with an EC50 of 28.6 microg/ml.
  • Imperatorin and xanthotoxin, the main furanocoumarins, were identified as potent antiproliferative agents (EC50: 2.7 and 3.7 microg/ml, respectively).
  • Terpenes showed negligible contribution to the antiproliferative effect.

Conclusions:

  • Furanocoumarins, specifically imperatorin and xanthotoxin, are the primary drivers of the antiproliferative activity of Angelica archangelica tincture against pancreatic cancer cells.
  • These findings support the potential of Angelica archangelica as a source for developing new pancreatic cancer therapies.

Related Concept Videos